Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Sydromes in China (CPACS) study. American Heart Journal. 2009; 157:509-516. .
Gaps in cardiovascular disease risk management in Australian general practice. Medical Journal of Australia. 2009;191:324-9..
How to Treat – Cardiovascular Disease Risk Assessment. Australian Doctor. 2009:25-31..
Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE. In: American Heart Association Scientific Sessions. American Heart Association Scientific Sessions. Orlando, US; 2009..
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288-98.
[Letter to the Editor] ADVANCE Blood pressure lowering in diabetes. Journal of Clinical Hypertension (Greenwich). 2009;11:108..
Management of cardiovascular risk factors in Australian General Practice of those at highest risk. Australasian Epidemiologist. 2009;16:6-11. ..
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009). 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. 2009;18(Suppl 3):S280.
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (September 2009). 6th Asia Pacific Conference Against Stroke. 2009.
Re-calibration of a Framingham Risk Equation for a Rural Population in India. Journal of Epidemiology and Community Health. 2009;63:379-85 ..
[Review] Trials of cardiovascular risk management in diabetes. Current Opinion in Cardiology. 2009;24:288-94. ..
Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation – results of the ADVANCE study. European Heart Journal. 2009;30 :1128-35.